ClinicalTrials.Veeva

Menu

Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis

National Jewish Health logo

National Jewish Health

Status

Completed

Conditions

Idiopathic Pulmonary Fibrosis

Treatments

Other: Pulmonary rehabilitation

Study type

Interventional

Funder types

Other

Identifiers

NCT00692796
NJMRC HS 1603 substudy

Details and patient eligibility

About

The purpose of this study is to determine the effects of Pulmonary Rehabilitation (PR) on shortness of breath, exercise capacity, symptom control, mental health, cognitive function, and quality of life in patients with Idiopathic Pulmonary Fibrosis (IPF). Pulmonary rehabilitation has already been shown to benefit patients with other chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD). We believe that pulmonary rehabilitation will benefit patients with IPF as well.

Full description

The goals of this project are to assess the effect of PR on a number of important outcomes in patients with IPF. Once enrolled in the study, subjects will complete a battery of questionnaires and tests that assess symptoms, quality of life, cognition, and mental health, and then subjects will complete a six week outpatient PR program (at National Jewish Medical and Research Center or other PR programs). Subjects will complete the same battery of questionnaires and tests immediately after completion of the PR program and again six months later.

Enrollment

60 patients

Sex

All

Ages

40 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 40 years or older
  • Diagnosis of IPF according to American Thoracic Society criteria

Exclusion criteria

  • Patients who have completed a PR program within the last two years
  • Patients with unstable medical conditions that would make PR unsafe

Trial design

60 participants in 1 patient group

1
Experimental group
Treatment:
Other: Pulmonary rehabilitation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems